Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127250373 | 12725037 | 3 | F | 20160830 | 20160913 | 20160908 | 20160926 | EXP | US-ACTELION-A-NJ2016-141846 | ACTELION | 51.00 | YR | A | F | Y | 0.00000 | 20160926 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127250373 | 12725037 | 1 | PS | UPTRAVI | SELEXIPAG | 1 | Oral | 400 MCG, BID | Y | Y | 207947 | 400 | UG | TABLET | BID | ||||
| 127250373 | 12725037 | 2 | SS | UPTRAVI | SELEXIPAG | 1 | Oral | 200 MCG, BID | Y | Y | 207947 | 200 | UG | TABLET | BID | ||||
| 127250373 | 12725037 | 3 | SS | UPTRAVI | SELEXIPAG | 1 | Oral | UNK | Y | Y | 207947 | TABLET | |||||||
| 127250373 | 12725037 | 4 | SS | AMBRISENTAN | AMBRISENTAN | 1 | Unknown | 10 MG, QD | 0 | 10 | MG | QD | |||||||
| 127250373 | 12725037 | 5 | SS | TORSEMIDE. | TORSEMIDE | 1 | Unknown | U | U | 0 | |||||||||
| 127250373 | 12725037 | 6 | SS | RIOCIGUAT | RIOCIGUAT | 1 | Unknown | U | U | 0 | |||||||||
| 127250373 | 12725037 | 7 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | U | 0 | |||||||||||
| 127250373 | 12725037 | 8 | C | AMBIEN | ZOLPIDEM TARTRATE | 1 | U | 0 | |||||||||||
| 127250373 | 12725037 | 9 | C | THYROID | LEVOTHYROXINELIOTHYRONINE | 1 | U | 0 | |||||||||||
| 127250373 | 12725037 | 10 | C | XARELTO | RIVAROXABAN | 1 | U | 0 | |||||||||||
| 127250373 | 12725037 | 11 | C | CLONAZEPAM. | CLONAZEPAM | 1 | U | 0 | |||||||||||
| 127250373 | 12725037 | 12 | C | TRAMADOL. | TRAMADOL | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127250373 | 12725037 | 1 | Pulmonary arterial hypertension |
| 127250373 | 12725037 | 4 | Pulmonary hypertension |
| 127250373 | 12725037 | 5 | Product used for unknown indication |
| 127250373 | 12725037 | 6 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127250373 | 12725037 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127250373 | 12725037 | Blood potassium decreased | |
| 127250373 | 12725037 | Hypotension | Hypotension |
| 127250373 | 12725037 | Pneumonia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127250373 | 12725037 | 1 | 20160830 | 0 | ||
| 127250373 | 12725037 | 2 | 20160831 | 20160831 | 0 | |
| 127250373 | 12725037 | 3 | 20160809 | 0 | ||
| 127250373 | 12725037 | 4 | 20160619 | 0 |